G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria

PHASE4CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Vivax Malaria
Interventions
DRUG

Chloroquine

10 mg/kg on day 0 \& 1 and 5mg/kg on day 2, (Afghanistan NMLCP guidelines)

DRUG

Primaquine 0.25 mg/kg/day

0.25 mg/kg/day for 14 days

DRUG

Primaquine 0.75 mg/kg weekly

0.75 mg/kg weekly for eight weeks

Trial Locations (1)

Unknown

Dr. Ghulam Rahim Awab MD, Jalalabad

All Listed Sponsors
collaborator

Mahidol Oxford Tropical Medicine Research Unit

OTHER

collaborator

Nangarhar University

OTHER

lead

University of Oxford

OTHER

NCT02876549 - G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria | Biotech Hunter | Biotech Hunter